Childhood Cancers

‘Try anything’ off-label approach in childhood cancer under the microscope

Off-label use of novel drugs in paediatric oncology is inconsistently documented, results in objective response in a majority of patients but ultimately fails to impact survival, an Australian study shows. A retrospective audit of practice at a tertiary paediatric oncology centre in Melbourne between 2010 and 2019 has identified 100 patients prescribed 133 drugs across ...

Already a member?

Login to keep reading.

© 2022 the limbic